Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
712
datasets available to search
ShareScore release 0.9.0
Dataset results
712 results for “mantle”
Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)
ClinicalTrials.gov study NCT04880434. IPD Sharing: NO. Countries: 6. Publications: 1.
A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01652144. IPD Sharing: NO. Countries: 1. Publications: 1.
Ibrutinib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Older Patients With Newly Diagnosed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01880567. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Venetoclax, Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03505944. IPD Sharing: NO. Countries: 4. Publications: 1.
Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01838434. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of OLR in First-line Treatment of Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05076097. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00992992. IPD Sharing: YES. Countries: 0. Publications: 1.
Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)
ClinicalTrials.gov study NCT04662255. IPD Sharing: NO. Countries: 24. Publications: 1.
Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma
ClinicalTrials.gov study NCT02356458. IPD Sharing: NO. Countries: 3. Publications: 1.
Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00516412. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00514475. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)
ClinicalTrials.gov study NCT01439750. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT02169180. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT02427620. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.
ClinicalTrials.gov study NCT00963534. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT02460276. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04626791. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial of Obinutuzumab,GDC-0199 Plus Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Patients
ClinicalTrials.gov study NCT02558816. IPD Sharing: NO. Countries: 2. Publications: 2.
Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05471843. IPD Sharing: YES. Countries: 15. Publications: 0.
Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00053092. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.